Details of the Drug Formulaction

General Information of Drug Formulation (ID: F00628)

• Formulation Name: Alendronic acid 35 mg tablet
• Company: Mylan Pharamceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Alendronate	(DMY2KX9)	Bone Paget disease		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Magnesium stearate	(E00208)	11177	lubricant
Mannitol	(E00103)	6251	Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant